期刊文献+

结核分枝杆菌利福平敏感性测定在耐多药结核病诊断中的价值 被引量:5

下载PDF
导出
摘要 目的评价结核分枝杆菌利福平敏感性测定在耐多药结核病(MDR-TB)诊断中的价值。方法对1994~2003年广州市老城区结核专科门诊肺结核病人药物敏感性测定资料和2000年全国结核病流行病学抽样调查结核分枝杆菌耐药情况调查资料进行分析,应用诊断性试验指标评价利福平敏感性测定作为MDR-TB诊断依据的科学性。结果若以至少同时耐利福平与异烟肼作为诊断MDR-TB的参照标准,以利福平敏感性测定作为MDR-TB诊断方法的敏感度、特异度、准确度、阳性预测值、阴性预测值、阳性似然比和阴性似然比分别为:100%、98.7%、98.8%、88.7%、100%、77.1、0;若以同时耐H、R或同时耐3种及以上主要抗结核药物作为诊断MDR-TB的参照标准,其敏感度、特异度、准确度、阳性预测值、阴性预测值、阳性似然比和阴性似然比分别为:97.0%、98.8%、98.6%、89.7%、99.7%、81.9、0.03。结论利福平敏感性测定是一种诊断水平高、成本-效益好的MDR-TB诊断方法。
出处 《国际医药卫生导报》 2006年第16期99-102,共4页 International Medicine and Health Guidance News
  • 相关文献

参考文献10

二级参考文献18

  • 1张敦熔.耐药性的流行病学意义[J].中国防痨杂志,1997,4:155-155.
  • 2全国结核病流行病学抽样调查领导小组.1979全国结核病流行病学抽样调查综合简报[J].中国防痨通讯,1982,2:3-6.
  • 3中华人民共和国卫生部.1984/1985全国结核病流行病学抽样调查资料汇编[M].,-.18-19.
  • 4Snider DE. Tuberculosis,the world situation. History of the disease and efforts to combat it. Tuberculosis back to the future. London School of Hygiene and Tropical Medicine[R]. Third Annual Public Health Forum,1993:13~33.
  • 5World Health Organization. Anti-tuberculosis drug resistance in the world. Report No.2. Prevalence and trends.Geneva:WHO, 2000.
  • 6Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol,1999,7:2663-2666.
  • 7Chatterjee S, Mitra M,Das Gupta SK. A high yielding mutant of mycobacteriophage L1 and its application as a diagnostic tool. FEMS Microbiol Lett,2000,188:47-53.
  • 8Bemer P, Palicova F, Rüsch-Gerdes S,et al. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol, 2002, 40:150-154.
  • 9McNerney R. TB:The return of the phage. A review of fifty years of mycobacteriophage research.Int J Tuberc Lung Dis,1999,3:179-184.
  • 10Wilson SM, al-Suwaidi Z, McNerney R, et al. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Micobacterium tuberculosis. Nat Med, 1997,3:465-468.

共引文献1456

同被引文献33

  • 1梅建,薛桢,沈鑫,沈国妙,桂晓红,沈梅,高谦.原发性耐药是耐药结核病产生的重要原因[J].中华结核和呼吸杂志,2006,29(2):75-78. 被引量:103
  • 2阴灵芳,陆学东,蒙世杰,王瑞.结核分枝杆菌rpoB基因突变的检测(简报)[J].分子细胞生物学报,2006,39(2):185-189. 被引量:3
  • 3赵雁林,尚美.我国结核病实验室诊断的现状[J].中华检验医学杂志,2007,30(7):725-728. 被引量:57
  • 4Drobniewski FA, Watterson SA, Wilson SM, et al. A clinical, micro- biological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in My- cobacterium tuberculosis [ J ]. J Med Microbiol, 2000,49 : 271 - 278.
  • 5Herrea L, Jimenz S, Valverde A, et al. Molecular analysis of rif- ampicin-resistant Mycobacterium tuberculosis isolated in Spain ( 1996 - 2001 ). Description of new mutations in the rpoB gene and review of the literature [ J ]. Int J Antimicrob Agents, 2003, 21 : 403 - 408.
  • 6Valim ARM, Rossetti MLR, Ribeiro MO, et al. Mutations in the rpoB gene in multidrug-resistant Mycobacterium tuberculosis isolates from Brazil[J]. J Cliu Microbiol, 2000,38:3110-3122.
  • 7Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis -criti- cal steps for prevention and control[ J]. N Engl J Med, 2010, 363 (11) : 1050-1058.
  • 8Gandhi NR, Nunn P, Dheda K, et al. Multidrug -resistant and ex- tensively drug - resistant tuberculosis : a threat to global control of tu- berculosis[J]. The Lancet, 2010, 375(9728) : 1830 - 1843.
  • 9Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituber- culosis drug resistance 2002 - 07 : an updated analysis of the Global Project on Anti -Tuberculosis Drug Resistance Surveillance[ J]. The Lancet, 2009, 373(9678) : 1861 - 1873.
  • 10Lomtadze N, Aspindzelashvili R, Janjgava M, et al. Prevalence and risk factors for multidrug - resistant tuberculosis in Republic of Georgia: a population based study[J]. Im J Tuberc Lung Dis, 2009, 13(1) : 68.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部